MRO Acquires Q-Centrix in Strategic Data Expansion
Deal News | Jun 12, 2025 | Parthenon Capital LLC
MRO Corporation, a leader in clinical data exchange, has acquired Q-Centrix, a top enterprise clinical data management platform, to enhance the integration and actionable use of clinical data across the healthcare ecosystem. This union is supported by Parthenon Capital, which made a significant investment as part of the deal. The acquisition consolidates over 2,000 hospitals and health systems, 7,000 clinics, and improves data management capabilities throughout healthcare. The integration aims to transform raw clinical records into structured, enriched data that facilitates improved patient care and operational efficiencies. The financial details of the transaction remain undisclosed.
Sectors
- Healthcare Technology
- Private Equity
Geography
- United States – MRO is based in Norristown, Pennsylvania, indicating that the primary activities and their impact are concentrated in the U.S. healthcare market.
Industry
- Healthcare Technology – The article discusses the acquisition related to the exchange and management of clinical data within the healthcare sector, highlighting advancements in healthcare technology.
- Private Equity – Parthenon Capital, a private equity firm, plays a key role in supporting the acquisition through new investments in MRO.
Financials
- Not Disclosed – The financial terms of the acquisition between MRO and Q-Centrix were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MRO Corporation | Acquiring Company | Company | A leading clinical data exchange company in healthcare focused on leveraging clinical data to improve patient care and operational efficiencies. |
| Q-Centrix Corp. | Target Company | Company | A pioneer in the enterprise clinical data management platform that enhances performance through curated data sets. |
| Parthenon Capital | Private Equity Firm / Investor | Company | A growth-oriented private equity firm that invests in MRO to support its acquisition and growth strategies. |
| TPG Growth | Selling Company | Company | Part of global asset management firm TPG, selling its stake in Q-Centrix to MRO. |
| Jason Brown | CEO of MRO | Person | CEO of MRO, expressing the potential value in clinical data exchange through the acquisition. |
| Milton Silva-Craig | CEO of Q-Centrix | Person | CEO of Q-Centrix, commenting on the innovation and integration of the companies' platforms. |